Denise Roland

The British drugmaker is reducing production of its Covid-19 vaccine and betting on new therapies for other conditions to help boost its growth.

Bavarian Nordic, the world’s sole supplier of a licensed vaccine for monkeypox, is being inundated with orders.

The country is the first to clear Moderna’s so-called bivalent shot, which targets the original strain of the virus as well as the Omicron variant.

Bavarian Nordic worked for decades on a vaccine and suddenly, orders are coming in now.

An international investigation yielded a new hypothesis: Research suggests a pair of viruses working in concert triggered the liver inflammation in children with a certain genetic susceptibility.

The pharmaceuticals giant completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth.

The British pharmaceutical giant agreed to acquire the vaccine maker in a deal that would hand it a new vaccine technology targeting common bacterial diseases such as meningitis and pneumonia.

Stomach bugs, Covid-19 and a normally harmless virus are among the suspects researchers have identified as possible drivers of a mysterious rash of hepatitis cases among children.

Public-health authorities are studying severe hepatitis cases in dozens of children, with a possible link to the viruses that cause the common cold and Covid-19.

The British pharmaceutical giant will buy Sierra Oncology in a deal centered on momelotinib, a drug to treat patients with a rare type of bone marrow cancer who have developed anemia.

Healthcare companies say they are duty-bound to continue supplying drugs, vaccines and medical equipment to Russia, though Western sanctions have thrown up hurdles.

Three shots of vaccine cut the risk of death from Covid-19 by 95% in those age 50 and older during the Omicron surge in the U.K., according to an early study.

Researchers are trying to determine whether boosting with an Omicron-specific vaccine would only reawaken an earlier immune response, offering no advantage over simply boosting with the shots already in use.

GlaxoSmithKline and Vir said their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies, even as early data suggests that similar treatments work less well against the strain.

David Julius and Ardem Patapoutian won this year’s Nobel Prize in Physiology or Medicine for their work on how the human body senses temperature, touch and movement.

Manufacturers of pacemakers, ultrasound machines and other medical devices emphasize their life-saving products to secure supply of computer chips.

The results provide some of the most detailed analysis yet of severe illness and death from the virus in children, a closely watched subject as schools prepare for a new academic year.

The concept, called QALY, places a dollar value on the health medicines can restore. The calculations are “starting to influence decision-making.”

Academics in historic university town worry that Britain’s departure from the European Union will spark an exodus of talented researchers and render the city less attractive to the bioscience and tech companies that have fueled an economic boom.

Treximet, a migraine drug, is just one of many treatments whose active ingredients are generic drugs that can be purchased separately at a fraction of the cost.